the invention belongs to the field of chemistry \u0444\u0430\u0440\u043c\u0430\u043a\u043e\u043b\u043e\u0433\u0438\u0447\u0435\u0441\u043a\u0438 active \u0433\u0435\u0442\u0435\u0440\u043e\u0446\u0438\u043a\u043b\u0438\u0447\u0435\u0441\u043a\u0438\u0445 compounds of natural origin, specifically to \u0432\u043e\u0434\u043e\u0440\u0430\u0441\u0442\u0432\u043e\u0440\u0438\u043c\u043e\u0439 \u0447\u0435\u0442\u0432\u0435\u0440\u0442\u0438\u0447\u043d oh form \u0430\u043b\u043a\u0430\u043b\u043e\u0438\u0434\u0430 \u0433\u0430\u0440\u043c\u0438\u043d\u0430: 7 - \u043c\u0435\u0442\u043e\u043a\u0441\u0438 - 1 - methyl - 9\u043d - \u043f\u0438\u0440\u0438\u0434\u043e [3,4 - (b) \u0438\u043d\u0434\u043e\u043b - 2N - \u0433\u0438\u0434\u0440\u043e\u0445\u043b\u043e\u0440\u0438\u0434\u0443, which would broaden the range of medications used for the le of central nervous system diseases.on the basis of available plant \u0430\u043b\u043a\u0430\u043b\u043e\u0438\u0434\u0430 \u0433\u0430\u0440\u043c\u0438\u043d\u0430 synthesized his \u0432\u043e\u0434\u043e\u0440\u0430\u0441\u0442\u0432\u043e\u0440\u0438\u043c\u0430\u044f salt.experimentally, it is found that the compound in doses of 2.5 and 5 mg \/ kg has \u0430\u043d\u0434\u0435\u043f\u0440\u0435\u0441\u0441\u0438\u0432\u043d\u043e\u0439 activity comparable to the activity of elavil in a dose of 10 mg \/ kg. and is \u0430\u043d\u0442\u0438\u043f\u0430\u0440\u043a\u0438\u043d\u0441\u043e\u043d\u0438\u0447\u0435\u0441\u043a\u043e\u0435 effects, comparable with the activity of the drug \"l-dopa\" in a dose of 50 m \/ kg, which is expressed with \u043a\u0430\u0442\u0430\u043b\u0435\u043f\u0441\u0438\u0438 in rats caused by in \u0433\u0430\u043b\u043e\u043f\u0435\u0440\u0438\u0434\u043e\u043b\u043e\u043c, and reducing the \u043e\u043b\u0438\u0433\u043e\u043a\u0438\u043d\u0435\u0437\u0438\u0438 and stiffness in test operationcaused by a neurotoxin and \u043c\u0444\u0442\u043f mice line C57BL \/ 6, and also has \u043f\u0440\u043e\u0442\
